ArticleIn vivo (Athens, Greece)

FGF10/FGFR2 Signaling: Therapeutically Targetable Vulnerability in Ligand-responsive Cholangiocarcinoma Cells.

Kimyeun Oeurn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.